Lieff Cabraser attorney Lexi J. Hazam will be speaking at HarrisMartin’s MDL Conference: Xarelto, Morcellators and Emerging Torts on March 25, 2015 at The Westin San Diego. Hazam will be featured on a panel discussing the prescription drug Benicar. Hazam will also be addressing the science behind the plaintiffs’ claims.
Lexi Hazam Discusses Benicar Side Effect Injuries and Lawsuits
Hazam is an emerging leader within the plaintiffs’ bar, representing clients in mass torts cases and qui tam actions, along with complex class actions. She currently represents several hundred hip replacement patients in litigation over the DePuy ASR, in which the firm has recovered over $30 million for clients so far, the DePuy Pinnacle metal-on-metal, and Stryker Rejuvenate. Her qui tam cases include the $68 million settlement of litigation against Office Depot for overcharging California school districts and cities for school supplies; the $21.7 million settlement of litigation against Avaya, Lucent Technologies, and AT&T for charging governmental agencies for the lease of communications systems they no longer possessed; and several other cases alleging Medicare fraud.